Join to View Full Profile
55 Fruit StreetBoston, MA 02114
Dr. Gao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2015
Harvard Medical SchoolClass of 2012
Certifications & Licensure
MA State Medical License 2012 - 2026
NH State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 May 21
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Jul 22
Roles: Principal Investigator
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Start of enrollment: 2022 Mar 29
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Reversible downregulation of HLA class I in adenoid cystic carcinoma.Annie Li, Bianca L Gonda, Elizabeth M Codd, Adam von Paternos, Dawn R Mitchell
Journal for Immunotherapy of Cancer. 2025-04-20 - A phase I dose escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear cell renal cell carcinoma.Sumanta K Pal, Alice Bernard-Tessier, Peter Grell, Xin Gao, Ritesh R Kotecha
Clinical Cancer Research. 2025-03-05 - A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.Gregory M Cote, Bose S Kochupurakkal, Khanh Do, Andrea Bullock, Michael L Cheng
Clinical Cancer Research. 2025-01-06
Journal Articles
- Combination Immunotherapy and Targeted Therapy: Will New Combinations Raise the Tail of the Survival Curve?Gao X, Kidney Cancer Journal, 10/7/2018
Press Mentions
Enzalutamide Survival Benefit in Metastatic Prostate Cancer Persists Beyond Five YearsJune 20th, 2022- Diving Deeper into Benefit of Avelumab Maintenance in Bladder CancerJune 24th, 2021
Weymouth Kidney Cancer Victim’s Memory Fuels MGH Research FundraiserNovember 13th, 2019
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
